Quality of Life in Hypoparathyroidism Improves with rhPTH(1-84) Throughout 8 Years of Therapy.

Gaia Tabacco,Yu Kwang Donovan Tay,Natalie E. Cusano,John C. Williams,Beatriz Omeragic,Rukshana Majeed,Maximo Gomez Almonte,Mishaela R. Rubin,John P. Bilezikian

Quality of Life in Hypoparathyroidism Improves with rhPTH(1-84) Throughout 8 Years of Therapy.

2019

Gaia Tabacco
Yu Kwang Donovan Tay
Natalie E. Cusano
John C. Williams
Beatriz Omeragic
Rukshana Majeed
Maximo Gomez Almonte
Mishaela R. Rubin
John P. Bilezikian

Context Calcium and vitamin D treatment does not improve reduced quality of life (QOL) in hypoparathyroidism. Recombinant human (rh) PTH(1-84) therapy improves QOL metrics for up to 5 years. Data on QOL beyond this time point are not available.

Keywords:

Hypoparathyroidism
Endocrinology
Pediatrics
Internal medicine
Diabetes mellitus
Medicine
Quality of life
Disease
Mental health
Vitamin D and neurology
Cohort
Calcitriol

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations